Cargando…
Effect of Metformin-sustained Release Therapy on Low-density Lipoprotein Size and Adiponectin in the South Indian Women with Polycystic Ovary Syndrome
OBJECTIVES: The aim of the study is to compare surrogate markers of cardiovascular disease (CVD) risk, such as adiponectin (APN) levels and low-density lipoprotein (LDL) size, before and after sustained release metformin (Met-SR) therapy in women with polycystic ovarian syndrome (PCOS). METHODS: Six...
Autores principales: | Kumar, D. Rama Nagendra, Seshadri, Krishna G., Pandurangi, Monna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628535/ https://www.ncbi.nlm.nih.gov/pubmed/28989873 http://dx.doi.org/10.4103/ijem.IJEM_154_17 |
Ejemplares similares
-
Serum adiponectin in Indian women with polycystic ovary syndrome
por: Rajendra, Aishwarya, et al.
Publicado: (2023) -
Association of adiponectin levels with polycystic ovary syndrome among Indian women
por: Patil, Sudha, et al.
Publicado: (2022) -
Adiponectin in Women with Polycystic Ovary Syndrome
por: Shin, Hyun-Young, et al.
Publicado: (2011) -
Correlation between serum adiponectin and clinical characteristics, biochemical parameters in Indian women with polycystic ovary syndrome
por: Ramanand, Sunita J., et al.
Publicado: (2014) -
Total cholesterol/high-density lipoprotein and inflammatory parameters in patients with polycystic ovary syndrome
por: Gülücü, Selim, et al.
Publicado: (2022)